Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nicolas Triltsch"'
Autor:
Manuel A Silva, Nicolas Triltsch, Simon Leis, Ivan Kanchev, Tze Heng Tan, Benjamine Van Peel, Marian Van Kerckhoven, Vanessa Deschoolmeester, Johannes Zimmermann
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 6, Iss 2, Pp 124-137 (2020)
Abstract Anti‐PD‐1/PD‐L1 immunotherapy could offer an alternative to traditional chemo‐ and/or radiotherapy to treat pediatric cancer patients. To unveil the potential benefit of this new therapeutic approach, the prevalence of PD‐L1 and ot
Externí odkaz:
https://doaj.org/article/014f5cb6069a4cacbf67b52399daeb3c
Autor:
Benjamine Van Peel, Marian Van Kerckhoven, Ivan Kanchev, Vanessa Deschoolmeester, Manuel A. Silva, Simon Leis, Tze Heng Tan, Nicolas Triltsch, Johannes Zimmermann
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 6, Iss 2, Pp 124-137 (2020)
The Journal of Pathology: Clinical Research
The Journal of Pathology: Clinical Research
Anti‐PD‐1/PD‐L1 immunotherapy could offer an alternative to traditional chemo‐ and/or radiotherapy to treat pediatric cancer patients. To unveil the potential benefit of this new therapeutic approach, the prevalence of PD‐L1 and other relev
Autor:
Hadassah Sade, Ansh Kapil, Philipp Wortmann, Andreas Spitzmueller, Nicolas Triltsch, Lina Meinecke, Susanne Haneder, Anatoliy Shumilov, Jan Lesniak, Valeria Bertani, Tze-Heng Tan, Ana Hidalgo-Sastre, Simon Christ, Andrea Storti, Regina Alleze, Dasa Medrikova, Jessica Chan, Simon Lanzmich, Markus Schick, Guenter Schmidt, J. Carl Barrett
Publikováno v:
Cancer Research. 82:468-468
Many targeted cancer therapies rely on biomarkers, which are assessed by standard pathologist scoring of immunohistochemically stained tissue. However, this process is subjective, semi-quantitative and does not assess expression heterogeneity. A quan